Literature DB >> 27453380

Redaction of Substance Abuse Claims in Medicare Research Files Affects Spending Outcomes for Nearly One in Five Beneficiaries with Serious Mental Illness.

Pamela Roberto1,2, Nicole Brandt3, Eberechukwu Onukwugha1, Bruce Stuart1.   

Abstract

OBJECTIVE: To assess the impact of substance abuse claims redaction on Medicare spending estimates for beneficiaries with serious mental illness. DATA SOURCES: The 2012 claims and unredacted beneficiary-level Medicare spending totals from CMS's Chronic Conditions Warehouse. STUDY
DESIGN: We identified beneficiaries with claims affected by the redaction by comparing claims-based spending estimates to unredacted spending totals. Differences in characteristics of beneficiaries with and without redacted claims were examined in bivariate analyses. PRINCIPAL
FINDINGS: Claims-based spending totals differed from unredacted totals for 19.7 percent of the cohort. Part A spending for those with redacted claims was underreported by 57.0 percent. Characteristics of beneficiaries with and without redacted claims differed significantly.
CONCLUSIONS: Researchers who rely on Medicare claims to analyze spending outcomes for beneficiaries with serious mental illness should be aware of the potential for bias due to nonrandom redaction of substance abuse data. © Health Research and Educational Trust.

Entities:  

Keywords:  Medicare spending; Substance abuse claims redaction; selection bias

Mesh:

Year:  2016        PMID: 27453380      PMCID: PMC5441491          DOI: 10.1111/1475-6773.12528

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  3 in total

1.  Protection or harm? Suppressing substance-use data.

Authors:  Austin B Frakt; Nicholas Bagley
Journal:  N Engl J Med       Date:  2015-04-15       Impact factor: 91.245

2.  Comorbidity of severe psychotic disorders with measures of substance use.

Authors:  Sarah M Hartz; Carlos N Pato; Helena Medeiros; Patricia Cavazos-Rehg; Janet L Sobell; James A Knowles; Laura J Bierut; Michele T Pato
Journal:  JAMA Psychiatry       Date:  2014-03       Impact factor: 21.596

3.  Suppression of Substance Abuse Claims in Medicaid Data and Rates of Diagnoses for Non-Substance Abuse Conditions.

Authors:  Kathryn Rough; Brian T Bateman; Elisabetta Patorno; Rishi J Desai; Yoonyoung Park; Sonia Hernandez-Diaz; Krista F Huybrechts
Journal:  JAMA       Date:  2016-03-15       Impact factor: 56.272

  3 in total
  4 in total

1.  Association Between Telemedicine Use in Nonmetropolitan Counties and Quality of Care Received by Medicare Beneficiaries With Serious Mental Illness.

Authors:  Bill Wang; Haiden A Huskamp; Sherri Rose; Alisa B Busch; Lori Uscher-Pines; Pushpa Raja; Ateev Mehrotra
Journal:  JAMA Netw Open       Date:  2022-06-01

2.  Long-Term Implications Of A Short-Term Policy: Redacting Substance Abuse Data.

Authors:  Andrea M Austin; Julie P W Bynum; Donovan T Maust; Daniel J Gottlieb; Ellen Meara
Journal:  Health Aff (Millwood)       Date:  2018-06       Impact factor: 6.301

3.  Association of Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence With the Risk of Subsequent Psychotic Disorder: A Systematic Review and Meta-analysis.

Authors:  Mikaïl Nourredine; Adrien Gering; Pierre Fourneret; Benjamin Rolland; Bruno Falissard; Michel Cucherat; Marie-Maude Geoffray; Lucie Jurek
Journal:  JAMA Psychiatry       Date:  2021-05-01       Impact factor: 21.596

4.  Estimates of ACO savings in the presence of provider and beneficiary selection.

Authors:  Mariétou H Ouayogodé; Ellen Meara; Kate Ho; Christopher M Snyder; Carrie H Colla
Journal:  Healthc (Amst)       Date:  2021-01-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.